Protective activity of guanosine in an in vitro model of Parkinson's disease

Panminerva Medica

Volumn 54, Issue 4 SUPPL. 1, 2012, Pages 43-51

  Giuliani, P ^a   Romano, S ^a   Ballerini, P ^a   Ciccarelli, R ^a   Petragnani, N ^a   Cicchitti, S ^a   Zuccarini, M ^a   Jiang, S ^b   Rathbone, M P ^b   Caciagli, F ^a   Di Iorio, P ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

6 OHDA; Parkinson's disease; SH SY5Y cells Lines of guanosine

Indexed keywords

GUANOSINE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPROTECTIVE AGENT; OXIDOPAMINE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIUM; DNA FRAGMENTATION; DOSE RESPONSE; DRUG EFFECT; HUMAN; METABOLISM; PARKINSON DISEASE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CULTURE MEDIA; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANOSINE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARKINSON DISEASE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

EID: 84876553838     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Birkmayer W, Hornykiewicz O. The effect of L-3,3-dihydroxyphe-nylalanine (L-DOPA) on akinesia in Parkinsonism. Wien Klin Wo-chenschr 1961; 73:787-788.
2. English translation, Parkinsonism and Related Disorders 1998;4:59-60.
3. Dauer W, Przedborski S. Parkinson's disease: Mechanisms and models. Neuron 2003;39:889-909.
4. Ungerstedt U, Ljungberg T, Steg G. Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons. Adv Neurol 1974;5:421-426.
5. Rodriguez Diaz M, Abdala P, Barroso-Chinea P, Obeso J, Gonzalez-Hernandez T. Motor behavioural changes after intracerebroven-tricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease. Behav Brain Res 2001;122:79-92.
6. Choi WS, Eom DS, Han BS, Kim WK, Han BH, Choi EJ et al. Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem 2004;279:20451-20460.
7. Klintworth H, Newhouse K, Li T, Choi WS, Faigle R, Xia Z. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis. Toxicol Sci 2007;97:149-162.
8. Ochu EE, Rothwell NJ, Waters CM. Caspases mediate 6-hydroxydopamine induced apoptosis but not necrosis in PC 12 cells. J Neurochem 1998; 70:2637-2640.
9. Ding YM, Jaumotte JD, Signore AP, Zigmond MJ. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. J Neurochem 2004;89:776-787.
10. Elkon H, Melamed E, Offen D. 6-Hydroxydopamine increases ubiquitin conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease. Cell Mol Neurobiol 2001; 21:771-781.
11. von Coelln R, Kugler S, Bahr M, Weller M, Dichgans J, Schulz JB. Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J Neurochem 2001;77:263-273.
12. Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MA, Reed JK et al. Trophic effects of purines in neurons and glial cells. Prog Neurobiol 1999;59:663-690.
13. Jiang S, Bendjelloul F, Ballerini P, D'Alimonte I, Nargi E, Jiang C et al. Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury. Purinergic Signalling 2007;3:411-421.
14. Di Iorio P, Ballerini P, Traversa U, Nicoletti F, D'Alimonte I, Kleywegt et al. The antiapoptotic effect of guanosine is mediated by the activation of the PI 3-kinase/AKT/PKB pathway in cultured rat astrocytes. Glia 2004;46:356-368.
15. Pettifer KM, Kleywegt S, Bau CJ, Ramsbottom JD, Vertes E, Ciccarelli R et al. Guanosine protects SH-SY5Y cells against beta-amyloid-induced apoptosis. Neuroreport 2004;15:833-836.
16. McNaught KS, Perl DP, Brownell AL, Olanow CW. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol 2004;56:149-162.
17. Su C, Elfeki N, Ballerini P, D'Alimonte I, Bau C, Ciccarelli R et al. Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism. J Neurosci Res 2009;87:617-25.
18. Oses JP, Batassini C, Pochmann D, Böhmer AE, Vuaden FC, Silves-trin RB et al. The hydrolysis of striatal adenine- and guanine-based purines in a 6-hydroxydopamine rat model of Parkinson's disease. Neurochem Res 2011; 36(2):215-22.
19. Loeffler DA, LeWitt PA, Juneau PL, Camp DM, DeMaggio AJ, Milbury P et al. Altered guanosine and guanine concentrations in rabbit striatum following increased dopamine turnover. Brain Res Bull 1998;45(3):297-9.
20. Pettifer KM, Jiang S, Bau C, Ballerini P, D'Alimonte I, Werstiuk ES et al. MPP(+)-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine. Purinergic Signal 2007;3(4):399-409.
21. D'Alimonte I, Flati V, D'Auro M, Toniato E, Martinotti S, Rathbone MP et al. Guanosine inhibits CD40 receptor expression and function induced by cytokines and beta amyloid in mouse microglia cells. J Immunol 2007;178(2):720-31.
22. Parkinson FE, Ferguson J, Zamzow CR, Xiong W. Gene expression for enzymes and transporters involved in regulating adenosine and inosine levels in rat forebrain neurons, astrocytes and C6 glioma cells. J Neurosci Res 2006;84(4):801-8.
23. Ouyang M, Shen X. Critical role of ASK1 in the 6-hydroxy-dopamine induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 2006;97:234-244.
24. Chao J, Yu MS, Ho YS, Wang M, Chang RC. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic Biol Med 2008; 45:1019-1026.
25. Guo S, Bezard E, Zhao B. Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol Med 2005; 39:682-695.
26. Nagasawa K, Kawasaki F, Tanaka A, Nagai K, Fujimoto S. Characterization of guanine and guanosine transport in primary cultured rat cortical astrocytes and neurons. Glia 2007;55 (14): 1397-404.
27. Traversa U, Bombi G, Di Iorio P, Ciccarelli R, Werstiuk ES, Rath-bone MP. Specific [(3)H]-guanosine binding sites in rat brain membranes. Br J Pharmacol 2002;135(4):969-76.
28. Traversa U, Bombi G, Camaioni E, Macchiarulo A, Costantino G, Palmieri C et al. Rat brain guanosine binding site. Biological studies and pseudo-receptor construction. Bioorg Med Chem 2003; 11(24):5417-25.
29. Brunet A, Datta SR, Greenberg ME. Transcription dependent and -independent control of neuronal survival by the PI3 K-Akt signaling pathway. Curr Opin Neurobiol 2001;11:297-305.
30. Luo HR, Hattori H, Hossain MA, Hester L, Huang Y, Lee-Kwon W et al. Akt as a mediator of cell death. Proc Natl Acad Sci USA 2003;100:11712-11717.
31. Giuliani P, Ballerini P, Ciccarelli R, Buccella S, Romano S, D' Alimonte I et al. Tissue distribution and metabolism of guanosine in rats following intraperitoneal injection. J Biol Regui Homeost Agents 2012; 26(1):51-65.